While the study observed if succinylcholine triggered MH, their methods provided little insight. The risk of MH with versus without succinylcholine both exceeded 1.
Researchers concluded that until more epidemiologic data is collected, having dantrolene available where both succinylcholine and volatile anesthetics are administers should be continued.
More Articles on Anesthesia:
FDA Recalls Bunnell Ventilator Patient Circuits
Tennessee Anesthesia, Texas Pediatric Surgery Practices Acquired by MEDNAX
Children’s Pain Scores Tied to Ethnicities
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.